Opening of Bids - Water Works North Station Well No 1 Replacement Project No 117-031R - Peerless Midwest Inc

Home Browse Search

Dru Tests The drugs that will be tested for include marijuana (THC), cocaine, opiates, amphetamines, and phencyclidine (PCP), Urine specimens will be conducted using the split specimen sample method as described in 49 CFR Pat 40. Each specimen will be accompanied by a DOT Chain of Custody and Control Form (CCF) and identified using a unique identification number that attributes the specimen to the correct individual. The specimen will be sent to a laboratory where a validity test will be performed to ensure that it is non -adulterated human urine. Then an initial drug screen test will be conducted on the primary specimen. For the primary specimen that is no negative, a confirmatory Gas Chromatography/Mass Spectrometry (GC/MS) test will be performed. The primary test will be considered positive if the amounts present are above the minimum thresholds established in 49 CFR Part 40. All test results from the laboratory will be, reported to a Medical Review Officer (MRO). The MRO is a licensed physician with detailed knowledge of substance abuse disorders and drug testing. The MRO will be knowledgeable in the DOT regulations and MRO guidelines, DOT operating administration regulations and any changes to any of these. The MRO must obtain the appropriate qualification training as mandated in 49 CFR Part 40. The MRO will review all test results to ensure the scientific validity of the test and to determine whether there is a legitimated medical explanation for a confirmed positive test result. The MRO will contact the employee, notify him/her of the positive laboratory result, and provide the employee with an opportunity to explain the confirmed test result. The MRO will subsequently review the employee's medical history/records to determine whether there is a legitimate medical explanation for the positive test result. If no legitimate medical explanation is found, he test will be verified positive and reported to the Peerless -Midwest Inc. Designated Employee Representative (DER). If a legitimate medical explanation is found, the MRO will report the test result as negative. The split specimen sample will be stored at the initial laboratory until the analysis of the primary specimen is complete. If the primary specimen is negative, the split sample will be discarded. However, if the primary specimen is positive, the split sample specimen will be retained by the initial laboratory for testing if so requested by the employee through the MRO within 72 hours of being notified. The split sample specimen, if requested to be tested, will be sent to an alternate certified laboratory for testing, at the expense of the employee or applicant. 1. The Collector must complete mandated qualification training as defined in 49 CFR Part 40 to be able to perform collections. 5